Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stents | 7 | 2013 | 117 | 1.580 |
Why?
|
| Coronary Angiography | 8 | 2014 | 150 | 1.490 |
Why?
|
| Myocardial Infarction | 6 | 2014 | 342 | 1.410 |
Why?
|
| Coronary Artery Disease | 5 | 2014 | 216 | 1.320 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 2013 | 52 | 1.320 |
Why?
|
| Coronary Vessels | 4 | 2015 | 151 | 1.270 |
Why?
|
| Atherectomy | 3 | 2012 | 11 | 1.210 |
Why?
|
| Femoral Artery | 3 | 2013 | 58 | 1.210 |
Why?
|
| Aorta | 3 | 2014 | 123 | 0.930 |
Why?
|
| Acute Coronary Syndrome | 3 | 2014 | 63 | 0.860 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2014 | 4 | 0.850 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 47 | 0.850 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 30 | 0.820 |
Why?
|
| Lower Extremity | 2 | 2014 | 84 | 0.810 |
Why?
|
| Middle Aged | 22 | 2018 | 6918 | 0.790 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2015 | 287 | 0.780 |
Why?
|
| Peripheral Arterial Disease | 3 | 2013 | 119 | 0.780 |
Why?
|
| Troponin I | 2 | 2021 | 14 | 0.770 |
Why?
|
| Humans | 41 | 2021 | 27175 | 0.750 |
Why?
|
| Angioplasty, Balloon | 5 | 2013 | 21 | 0.730 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 38 | 0.720 |
Why?
|
| Male | 23 | 2021 | 13034 | 0.650 |
Why?
|
| Cardiac Catheterization | 3 | 2014 | 112 | 0.630 |
Why?
|
| Postoperative Complications | 2 | 2013 | 607 | 0.590 |
Why?
|
| Radiography, Interventional | 2 | 2014 | 15 | 0.570 |
Why?
|
| Female | 22 | 2021 | 14658 | 0.550 |
Why?
|
| Treatment Outcome | 10 | 2014 | 2289 | 0.540 |
Why?
|
| Equipment Failure | 2 | 2013 | 31 | 0.520 |
Why?
|
| Aneurysm, False | 2 | 2013 | 18 | 0.510 |
Why?
|
| Heart Rupture | 1 | 2015 | 1 | 0.510 |
Why?
|
| Papillary Muscles | 1 | 2015 | 14 | 0.510 |
Why?
|
| Aorta, Thoracic | 2 | 2015 | 49 | 0.480 |
Why?
|
| Intracranial Embolism | 1 | 2014 | 6 | 0.470 |
Why?
|
| von Willebrand Disease, Type 2 | 1 | 2014 | 1 | 0.460 |
Why?
|
| Radiation Exposure | 1 | 2014 | 17 | 0.460 |
Why?
|
| Electrocardiography | 3 | 2015 | 391 | 0.460 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2014 | 5 | 0.460 |
Why?
|
| Renal Veins | 1 | 2014 | 7 | 0.450 |
Why?
|
| Nasal Decongestants | 1 | 2014 | 2 | 0.450 |
Why?
|
| Oxymetazoline | 1 | 2014 | 2 | 0.450 |
Why?
|
| Renal Artery | 1 | 2014 | 15 | 0.450 |
Why?
|
| Arteriovenous Malformations | 1 | 2014 | 16 | 0.450 |
Why?
|
| Torsades de Pointes | 1 | 2013 | 3 | 0.440 |
Why?
|
| Lidocaine | 1 | 2013 | 27 | 0.440 |
Why?
|
| Saphenous Vein | 1 | 2013 | 24 | 0.440 |
Why?
|
| Cardiac Tamponade | 1 | 2013 | 8 | 0.440 |
Why?
|
| Methadone | 1 | 2013 | 17 | 0.430 |
Why?
|
| Pheochromocytoma | 1 | 2013 | 9 | 0.430 |
Why?
|
| Hyperthyroidism | 1 | 2013 | 11 | 0.430 |
Why?
|
| Endocarditis, Bacterial | 1 | 2013 | 13 | 0.430 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2013 | 9 | 0.430 |
Why?
|
| Hematoma | 1 | 2013 | 26 | 0.430 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 26 | 0.420 |
Why?
|
| Impotence, Vasculogenic | 1 | 2013 | 1 | 0.420 |
Why?
|
| Syncope | 1 | 2013 | 10 | 0.420 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2013 | 44 | 0.420 |
Why?
|
| Myxoma | 1 | 2013 | 6 | 0.420 |
Why?
|
| Fibroma | 1 | 2013 | 6 | 0.420 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2013 | 117 | 0.420 |
Why?
|
| Heart Neoplasms | 1 | 2013 | 16 | 0.420 |
Why?
|
| Iliac Artery | 1 | 2013 | 19 | 0.420 |
Why?
|
| Catheters | 1 | 2013 | 23 | 0.420 |
Why?
|
| Vascular Fistula | 1 | 2012 | 3 | 0.420 |
Why?
|
| Device Removal | 1 | 2013 | 30 | 0.420 |
Why?
|
| Penis | 1 | 2013 | 16 | 0.420 |
Why?
|
| Ethanolamines | 1 | 2012 | 1 | 0.420 |
Why?
|
| Coronary Vasospasm | 1 | 2012 | 4 | 0.410 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2012 | 5 | 0.410 |
Why?
|
| Scimitar Syndrome | 1 | 2012 | 6 | 0.410 |
Why?
|
| Nitroglycerin | 1 | 2012 | 27 | 0.410 |
Why?
|
| Vascular Access Devices | 1 | 2012 | 4 | 0.410 |
Why?
|
| Fistula | 1 | 2012 | 17 | 0.410 |
Why?
|
| Benzopyrans | 1 | 2012 | 17 | 0.410 |
Why?
|
| Aneurysm, Ruptured | 1 | 2012 | 17 | 0.400 |
Why?
|
| Radiography | 4 | 2014 | 201 | 0.400 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 81 | 0.400 |
Why?
|
| Vasodilator Agents | 1 | 2012 | 79 | 0.400 |
Why?
|
| Coronary-Subclavian Steal Syndrome | 1 | 2012 | 1 | 0.400 |
Why?
|
| Heart Diseases | 1 | 2012 | 69 | 0.400 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2012 | 3 | 0.400 |
Why?
|
| Coronary Disease | 1 | 2012 | 118 | 0.390 |
Why?
|
| Subclavian Artery | 1 | 2012 | 14 | 0.390 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2012 | 15 | 0.390 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2012 | 7 | 0.390 |
Why?
|
| Atherosclerosis | 1 | 2013 | 95 | 0.390 |
Why?
|
| Coronary Stenosis | 1 | 2012 | 19 | 0.390 |
Why?
|
| Carotid Stenosis | 2 | 2009 | 25 | 0.390 |
Why?
|
| Shock, Cardiogenic | 1 | 2012 | 16 | 0.380 |
Why?
|
| Heparin | 1 | 2012 | 110 | 0.380 |
Why?
|
| Heart Failure | 1 | 2014 | 232 | 0.370 |
Why?
|
| Thrombosis | 1 | 2012 | 147 | 0.340 |
Why?
|
| Anticoagulants | 1 | 2012 | 293 | 0.330 |
Why?
|
| Spinal Fusion | 1 | 2012 | 145 | 0.330 |
Why?
|
| Endosonography | 1 | 2009 | 36 | 0.320 |
Why?
|
| Dextrocardia | 1 | 2008 | 1 | 0.320 |
Why?
|
| Situs Inversus | 1 | 2008 | 1 | 0.320 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 368 | 0.290 |
Why?
|
| Hydrogen Sulfide | 2 | 2018 | 32 | 0.250 |
Why?
|
| Adult | 7 | 2021 | 7510 | 0.250 |
Why?
|
| Ultrasonography | 3 | 2014 | 229 | 0.220 |
Why?
|
| Popliteal Artery | 2 | 2013 | 10 | 0.210 |
Why?
|
| Aged | 6 | 2018 | 5232 | 0.210 |
Why?
|
| Ischemia | 2 | 2014 | 83 | 0.210 |
Why?
|
| Sinus of Valsalva | 1 | 2002 | 12 | 0.200 |
Why?
|
| Young Adult | 3 | 2014 | 2636 | 0.200 |
Why?
|
| Coronary Artery Bypass | 2 | 2015 | 68 | 0.200 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 293 | 0.190 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 357 | 0.190 |
Why?
|
| Bilirubin | 1 | 2021 | 11 | 0.190 |
Why?
|
| Biomarkers | 2 | 2021 | 736 | 0.170 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2018 | 7 | 0.150 |
Why?
|
| Sulfides | 1 | 2018 | 38 | 0.150 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 9 | 0.130 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 21 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 33 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2013 | 37 | 0.120 |
Why?
|
| Aneurysm, Dissecting | 1 | 2014 | 12 | 0.120 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2464 | 0.120 |
Why?
|
| Viscera | 1 | 2014 | 18 | 0.120 |
Why?
|
| Hypertension, Renal | 1 | 2014 | 6 | 0.110 |
Why?
|
| Radiation Dosage | 1 | 2014 | 53 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2014 | 67 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2014 | 26 | 0.110 |
Why?
|
| Nasal Sprays | 1 | 2014 | 1 | 0.110 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2013 | 9 | 0.110 |
Why?
|
| Heart Aneurysm | 1 | 2013 | 10 | 0.110 |
Why?
|
| Opiate Substitution Treatment | 1 | 2013 | 5 | 0.110 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 37 | 0.110 |
Why?
|
| Debridement | 1 | 2013 | 10 | 0.110 |
Why?
|
| Retroperitoneal Space | 1 | 2013 | 9 | 0.110 |
Why?
|
| Pneumothorax | 1 | 2013 | 15 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2013 | 26 | 0.110 |
Why?
|
| Cocaine | 1 | 2013 | 21 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2013 | 36 | 0.110 |
Why?
|
| Fibrosis | 1 | 2013 | 121 | 0.100 |
Why?
|
| Postpartum Period | 1 | 2013 | 67 | 0.100 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2013 | 22 | 0.100 |
Why?
|
| Nebivolol | 1 | 2012 | 1 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2013 | 36 | 0.100 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 54 | 0.100 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2013 | 25 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 63 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 34 | 0.100 |
Why?
|
| Vascular Calcification | 1 | 2012 | 20 | 0.100 |
Why?
|
| Aortic Valve | 1 | 2013 | 90 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2013 | 67 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 1943 | 0.100 |
Why?
|
| Recurrence | 1 | 2013 | 317 | 0.100 |
Why?
|
| Minoxidil | 1 | 2012 | 1 | 0.100 |
Why?
|
| Vertebral Artery | 1 | 2012 | 16 | 0.100 |
Why?
|
| Pericardial Effusion | 1 | 2012 | 12 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2014 | 597 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2012 | 112 | 0.100 |
Why?
|
| Ticlopidine | 1 | 2012 | 34 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 56 | 0.100 |
Why?
|
| Time Factors | 2 | 2013 | 1573 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 205 | 0.100 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 163 | 0.090 |
Why?
|
| Equipment Design | 1 | 2012 | 212 | 0.090 |
Why?
|
| Aspirin | 1 | 2012 | 122 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 190 | 0.090 |
Why?
|
| Risk Factors | 1 | 2014 | 2043 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 498 | 0.080 |
Why?
|
| Neck Dissection | 1 | 2007 | 2 | 0.070 |
Why?
|
| Adolescent | 1 | 2014 | 2996 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 1 | 2007 | 22 | 0.070 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2006 | 9 | 0.060 |
Why?
|
| Diphosphonates | 1 | 2006 | 14 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 27 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 84 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 218 | 0.060 |
Why?
|
| Bone Density | 1 | 2006 | 99 | 0.060 |
Why?
|
| Radiography, Thoracic | 2 | 2015 | 12 | 0.060 |
Why?
|
| Stroke | 1 | 2007 | 241 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2003 | 30 | 0.050 |
Why?
|
| Echocardiography | 2 | 2014 | 108 | 0.050 |
Why?
|
| Angina, Unstable | 1 | 2003 | 19 | 0.050 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2002 | 7 | 0.050 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 2018 | 21 | 0.040 |
Why?
|
| Biological Availability | 1 | 2018 | 43 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 472 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 75 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 182 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 106 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2015 | 24 | 0.030 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2015 | 13 | 0.030 |
Why?
|
| African Americans | 1 | 2018 | 348 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 544 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2014 | 43 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2013 | 26 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2013 | 52 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2013 | 152 | 0.030 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2012 | 2 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 68 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 18 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2006 | 191 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 591 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 56 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2003 | 39 | 0.010 |
Why?
|
| Length of Stay | 1 | 2003 | 219 | 0.010 |
Why?
|
| Exercise Test | 1 | 2003 | 248 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 659 | 0.010 |
Why?
|